Hepatitis B surface antigen vaccine 0.04 mg/ML
RxNorm 830260
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 830260 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: hepatitis B surface antigen vaccine 0.04 mg/ML.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDCPrescribable
Semantic Clinical Drug Component (SCDC):
Hepatitis B surface antigen vaccine 0.04 mg/ML
(Atom ID: 12275125)
Patient Education
Hepatitis B Vaccine
Why get vaccinated against hepatitis B? Hepatitis B is a serious infection that affects the liver. It is caused by the hepatitis B virus. Hepatitis B can cause mild illness lasting a few weeks, or it can lead to a serious, lifelong illness. Hepatitis B virus infection can be either acute or chronic. Acute hepatitis B virus infection is a short-term illness that occurs within the first 6 months after someone is exposed to the hepatitis B virus. This can lead to: fever, fatigue, loss of appetite, nausea, and/or vomiting jaundice (yellow skin or eyes, dark urine, clay-colored bowel movements) pain in muscles, joints, and stomach Chronic hepatitis B virus infection is a long-term illness that occurs when the hepatitis B virus remains in a person's body. Most people who go on to develop chronic hepatitis B do not have symptoms, but it is still very serious and can lead to: liver damage (cirrhosis) liver cancer death Chronically infected people can spread hepatitis B virus to others, even if they do not feel or look sick themselves. Up to 1.4 million people in the United States may have chronic hepatitis B infection. About 90% of infants who get hepatitis B become chronically infected, and about 1 out of 4 of them dies. Hepatitis B is spread when blood, semen, or other body fluid infected with the hepatitis B virus enters the body of a person who is not infected. People can become infected with the virus through: birth (a baby whose mother is infected can be infected at or after birth) sharing items such as razors or toothbrushes with an infected person contact with the blood or open sores of an infected person sex with an infected partner sharing needles, syringes, or other drug-injection equipment exposure to blood from needlesticks or other sharp instruments Each year about 2,000 people in the United States die from hepatitis B–related liver disease. Hepatitis B vaccine can prevent hepatitis B and its consequences, including liver cancer and cirrhosis.
[Learn More]
* Please review the disclaimer below.
